Investigator Initiated Studies
We are committed to supporting independent research that aligns with our areas of interest.
Rezolute seeks study proposals evaluating the use of ersodetug in “Gastrointestinal Surgery Hypoglycemia” to assess its impact on the frequency and severity of such hypoglycemia and overall glycemic stability.
Download a PDF with details about the research proposal submission process for an investigator initiated study to evaluate the use of ersodetug in “Gastrointestinal Surgery Hypoglycemia.”
“Gastrointestinal Surgery Hypoglycemia” would include the spectrum of persistent or recurrent hyperinsulinemic hypoglycemia syndromes occurring following gastric or upper gastrointestinal surgery, irrespective of the original surgical indication, including:
- All forms of bariatric/metabolic surgery, including Roux-N-Y or Vertical Sleeve Gastrectomy
- Gastrectomy for malignancy
- Upper GI reconstructive surgery
- Antrectomy/vagotomy
- Esophagectomy with gastric pull-up
- Nissen fundoplication
- Whipple and related pancreato-intestinal surgeries, with or without insulin dependent brittle diabetes; and
- Other procedures associated with altered nutrient transit and dysregulated insulin secretion
Contact our Medical Affairs team to learn more.